Eikon Therapeutics, Inc.
EIKN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001861123
In the last 90 days, Eikon Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $344.1M in total; no superinvestor holds it.
Superinvestors holding EIKN, Q2 2026
No superinvestor reported holding EIKN in Q2 2026.